Evidence map›Paper›PMID 32251280›Full record

ArticleNature communications2020

Rapid expansion of Treg cells protects from collateral colitis following a viral trigger.

Michelle Schorer, Katharina Lambert, Nikolas Rakebrandt, Felix Rost, Kung-Chi Kao, Alexander Yermanos, Roman Spörri, Josua Oderbolz, Miro E Raeber, Christian W Keller and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Cell-drug conjugates.Nature biomedical engineering · 2024
    Review
  6. Innate acting memory Th1 cells modulate heterologous diseases.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. DEPs Induce Local Ige Class Switching Independent of Their Ability to Stimulate iBALT de Novo Formation.International journal of environmental research and public health · 2022
    Article
  11. Article
  12. Review
  13. Biologic Agents in Crohn's Patients Reduce CD4Canadian journal of gastroenterology & hepatology · 2022
    Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Michelle SchorerInstitute of Experimental Immunology, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland.
Katharina LambertInstitute of Experimental Immunology, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland.
Nikolas RakebrandtInstitute of Experimental Immunology, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland.
Felix RostInstitute of Experimental Immunology, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland.
Kung-Chi KaoInstitute of Experimental Immunology, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland.
Alexander YermanosInstitute of Microbiology, ETH Zurich, Vladimir-Prelog-Weg 1-5/10, 8093, Zurich, Switzerland.
Roman SpörriInstitute of Microbiology, ETH Zurich, Vladimir-Prelog-Weg 1-5/10, 8093, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-9277-6997
Josua OderbolzInstitute of Microbiology, ETH Zurich, Vladimir-Prelog-Weg 1-5/10, 8093, Zurich, Switzerland.
Miro E RaeberDepartment of Immunology, University Hospital Zurich, Häldeliweg 4, 8044, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-2609-0246
Christian W KellerInstitute of Experimental Immunology, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-2276-0003
Jan D LünemannInstitute of Experimental Immunology, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-3007-708X
Gerhard RoglerDepartment of Gastroenterology and Hepatology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
Onur BoymanDepartment of Immunology, University Hospital Zurich, Häldeliweg 4, 8044, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-8279-5545
Annette OxeniusInstitute of Microbiology, ETH Zurich, Vladimir-Prelog-Weg 1-5/10, 8093, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-2079-2354
Nicole JollerInstitute of Experimental Immunology, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland. nicole.joller@immunology.uzh.ch.ORCID http://orcid.org/0000-0003-1996-1672
University of Zurich · CHETH Zurich · CHUniversity Hospital of Zurich · CHVirginia Mason Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Foxp3

Indexed as

AutoimmunityAnimalsArenaviridae InfectionsCD8-Positive T-LymphocytesCell LineColitisColonForkhead Transcription FactorsGastrointestinal MicrobiomeHealthy VolunteersHost Microbial InteractionsHumansInterferon Type IIntestinal MucosaLymphocyte ActivationLymphocytic choriomeningitis virusForkhead Transcription FactorsFOXP3 protein, humanFoxp3 protein, mouseInterferon Type IReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID32251280
PMCPMC7090079
OpenAlexW3012770135

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.